Co-Founder and CEO Chris Barron to Present at LSI USA Emerging Medtech Summit

Written By Mateusz Zubrzycki
 

We are pleased to announce that EMBioSys Co-Founder and CEO, Chris Barron will be presenting at the LSI USA Emerging Medtech Summit on March 19, 2025.  This is a great opportunity to share the latest advancements for our iEF Therapy that offers new hope for women diagnosed with triple-negative breast cancer.

Mateusz Zubrzycki
Previous

Welcoming Dr. Sachin Jhawar to the Advisory Board
Next

Dr. Vish Subramaniam to Present Poster at AACR 2025